Activation of nuclear factor erythroid-2-related factor 2 (Nrf2) increases tumor cell resistance to chemotherapy and promotes growth, so there is an association between elevated tumor expression of Nrf2 protein and a poor prognosis [1–3]. This evidence concerns the gene NFE2L2 and neoplasm.